BENF.NASDAQBeneficient

Form 4: Beneficient Director Donegan Receives Stock Options and Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Patrick J. Donegan, a director of Beneficient, reports the acquisition of stock options and restricted stock units in the company.

Summary

  • On September 30, 2024, Patrick J. Donegan, a director of Beneficient, was granted 138,212 restricted stock units (RSUs) and stock options for 100,000 shares.
  • The RSUs will vest in four equal installments on the last day of each calendar quarter over a one-year period, contingent on Donegan's continued service to the Issuer.
  • The stock options, with an exercise price of $1.23, will vest in eight equal installments on the last day of each calendar quarter over a two-year period, also contingent on continued service.
  • Following these transactions, Donegan directly owns 138,212 shares of Class A Common Stock issuable upon settlement of the RSUs and holds options for 100,000 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects standard equity compensation practices, incentivizing a key director. There are no immediate negative implications.

Positives

  • The grant of RSUs and stock options to a director aligns their interests with the company's performance and shareholder value.
  • The vesting schedules incentivize continued service and commitment from the director.

Future Outlook

The RSUs and stock options are subject to vesting schedules, contingent on the director's continued service to the Issuer.

Industry Context

Equity compensation is a common practice for aligning the interests of company directors and management with those of shareholders. The specific terms of the grants, such as vesting schedules and exercise prices, are tailored to the company's specific circumstances and compensation philosophy.

Comparison to Industry Standards

  • Equity grants to directors are a standard practice across various industries to incentivize performance and align interests with shareholders.
  • Vesting schedules, like the quarterly vesting described, are common to ensure continued service and commitment.
  • The specific number of shares and option terms would need to be compared to similar companies in the financial services sector to assess competitiveness.

Stakeholder Impact

  • The equity grants align the director's interests with those of shareholders, potentially leading to decisions that benefit shareholder value.
  • The vesting schedules incentivize the director's continued service, which can benefit the company and its stakeholders.

Key Dates

DateDescription
09/30/2024Date of transaction: Grant of RSUs and stock options.
12/31/2024First vesting date for a portion of the stock options.
09/29/2034Expiration date of the stock options.
10/02/2024Date of signature on the Form 4 filing.

Keywords

Beneficient, Donegan, stock options, RSUs, restricted stock units, director, Class A Common Stock, equity incentive plan, Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.